News

News search

Latest news

Swedish Cherry Hill and Swedish Edmonds Recognized with the 2015 Get with the Guidelines-Stroke Quality Achievement Award
May 22, 2015

According to the American Heart Association/American Stroke Association (AHA/ASA), stroke is the number five cause of death and a leading cause of adult disability in the United States. On average, someone suffers a stroke every 40 seconds; someone dies every four minutes, and 795,000 people suffer a new or recurrent stroke each year.

Swedish is committed to increasing the quality of care and outcomes for stroke patients. Recently, Swedish Cherry Hill and Swedish Edmonds were recognized by the AHA/ASA's Get With The Guidelines®-Stroke Quality Achievement Awards. Swedish Cherry Hill received 'Gold' status with Target: Stroke Elite Plus Honor Roll. Swedish Edmonds received 'Gold Plus' status with Target: Stroke Elite Honor Roll.

Brian Livingston, M.D. Named Chief Executive and Vice President of Medical Affairs for Swedish Ballard
May 21, 2015

Swedish announced today that Brian Livingston, M.D., MBA, FACEP, current Vice President of Medical Affairs for Swedish First Hill, has been appointed Chief Executive and Vice President of Medical Affairs for Swedish Ballard. He will assume this new role on June 1, 2015.

Dr. Livingston has been an integral member of the Swedish physician leadership team since 2012, serving as Medical Director of Case Management and the Clinical Documentation Integrity Program, Interim Vice President of Operations for the Organ Transplant Program, Physician Advisor to Revenue Cycle, and Vice President of Medical Affairs. He joined Swedish in 2005, practicing in the First Hill Emergency Department.

New Release of Glioblastoma Atlas Sheds Light on Deadly Disease
May 14, 2015

Major updates to the Ivy Glioblastoma Atlas Project provide researchers with valuable tools to find cures for aggressive brain cancers

SEATTLE, WASH. — May 14, 2015 —Robust new data added to the Ivy Glioblastoma Atlas Project (Ivy GAP) changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for this most deadly and aggressive of brain cancers, glioblastoma multiforme.

Led by researchers at the Allen Institute for Brain Science and Swedish Neuroscience Institute and funded with a grant from The Ben and Catherine Ivy Foundation, Ivy GAP includes detailed information about genes expressed in the various anatomical regions of glioblastoma and important data about the presumed initial cancer stem cells that lead to tumor formation.